Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jul 31, 2021

Filed with the SEC on Sep 13, 2021 and accepted by EDGAR at Sep 13, 2021, 17:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-07-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-05-01 to 2021-07-31$11.3mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-05-01 to 2021-07-31$5.4mus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2021-05-01 to 2021-07-31$2.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-05-01 to 2021-07-31−$175.0kus-gaap:OperatingIncomeLoss
Income tax3 months2021-05-01 to 2021-07-31$14.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-05-01 to 2021-07-31−$172.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2021-05-01 to 2021-07-31−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-05-01 to 2021-07-31−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-05-01 to 2021-07-3113,401,929 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-05-01 to 2021-07-31$216.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-05-01 to 2021-07-31$907.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-07-31$4.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-07-31$12.6mus-gaap:AssetsCurrent
Total assetsAt period end2021-07-31$28.1mus-gaap:Assets
Current liabilitiesAt period end2021-07-31$11.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-07-31$20.6mus-gaap:Liabilities
Shareholders' equityAt period end2021-07-31$7.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-21-018495. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.